Clinical observation of quality of life in patients with gastric carcinoma treated by combination of traditional Chinese medicine, chemotherapy and hyperthermia treatment.

Objective To observe the effect of combined chemotherapy and hyperthermia in patients with advanced gastric cancer survival improvement of quality. Methods 120 patients with advanced gastric cancer patients were randomly divided into three groups, 40 cases of chemotherapy to chemotherapy alone, chemotherapy plus hyperthermia group of 40 patients to chemotherapy plus hyperthermia therapy, traditional Chinese medicine combined with chemotherapy and hyperthermia group of 40 patients to the combination of chemotherapy and traditional Chinese medicine hyperthermia combination therapy. 21 d as a course of treatment, the three groups were treated after two courses of clinical efficacy were KPS, body mass index (BM I) and the EORTC QLQ-C30 quality of life scale evaluation of the core. Results chemotherapy plus hyperthermia group compared with the chemotherapy group disease control rate higher (P0.05); Chinese medicine combined with chemotherapy and hyperthermia group effective (RR) rate, disease control rate than the chemotherapy group, chemotherapy plus hyperthermia group high (P0.01 ). Chinese medicine combined with chemotherapy and hyperthermia therapy KPS score, BM I compared with chemotherapy group, chemotherapy plus hyperthermia group increased (P0.05). Chemotherapy plus hyperthermia group after treatment pain score lower than before treatment in this group (P0.05), traditional Chinese medicine combined with chemotherapy and hyperthermia treatment of nausea, vomiting, pain, loss of appetite, fatigue scores were lower this group before treatment (P0 .05). Chinese medicine combined with chemotherapy and hyperthermia treatment of nausea, vomiting, pain, loss of appetite, fatigue scores compared with chemotherapy group, chemotherapy plus hyperthermia group lower (P0.01). The traditional Chinese medicine combined with chemotherapy and hyperthermia can significantly improve the quality of life of patients with advanced gastric cancer, worthy of clinical